Persister Development by Borrelia burgdorferi Populations In Vitro
- PMID: 26248368
- PMCID: PMC4576077
- DOI: 10.1128/AAC.00883-15
Persister Development by Borrelia burgdorferi Populations In Vitro
Abstract
Doxycycline is an antibiotic commonly used to treat Lyme disease and other bacterial infections. The MIC and minimum bactericidal concentration (MBC) for Borrelia burgdorferi have been investigated by different groups but were experimentally established in this study as a function of input cell density. We demonstrated that B. burgdorferi treated in the stationary phase has a higher probability of regrowth following removal of antibiotic. In addition, we determined experimentally and mathematically that the spirochetes which persist posttreatment do not have a longer lag phase but exhibit a lower growth rate than untreated spirochetes. Finally, we found that treating the spirochetes by pulse-dosing did not eliminate growth or reduce the persister population in vitro. From these data, we propose that B. burgdorferi persister development is stochastic and driven by slowed growth.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures



Similar articles
-
Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.PLoS One. 2015 Mar 25;10(3):e0117207. doi: 10.1371/journal.pone.0117207. eCollection 2015. PLoS One. 2015. PMID: 25806811 Free PMC article.
-
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.Antimicrob Agents Chemother. 2015 Aug;59(8):4616-24. doi: 10.1128/AAC.00864-15. Epub 2015 May 26. Antimicrob Agents Chemother. 2015. PMID: 26014929 Free PMC article.
-
In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.J Antimicrob Chemother. 2009 Apr;63(4):709-12. doi: 10.1093/jac/dkn551. Epub 2009 Jan 31. J Antimicrob Chemother. 2009. PMID: 19182236
-
Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.Arthritis Rheum. 2006 Oct;54(10):3079-86. doi: 10.1002/art.22131. Arthritis Rheum. 2006. PMID: 17009226 Review. No abstract available.
-
Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?Bosn J Basic Med Sci. 2015 Jul 8;15(3):1-13. doi: 10.17305/bjbms.2015.594. Bosn J Basic Med Sci. 2015. PMID: 26295288 Free PMC article. Review.
Cited by
-
A Practical Approach to the Diagnosis of Lyme Borreliosis: From Clinical Heterogeneity to Laboratory Methods.Front Med (Lausanne). 2020 Jul 23;7:265. doi: 10.3389/fmed.2020.00265. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32793606 Free PMC article. Review.
-
The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis.Front Neurol. 2018 Dec 3;9:1048. doi: 10.3389/fneur.2018.01048. eCollection 2018. Front Neurol. 2018. PMID: 30559713 Free PMC article. Review.
-
Extraction and Fractionation of Bioactives from Dipsacus fullonum L. Leaves and Evaluation of Their Anti-Borrelia Activity.Pharmaceuticals (Basel). 2022 Jan 12;15(1):87. doi: 10.3390/ph15010087. Pharmaceuticals (Basel). 2022. PMID: 35056144 Free PMC article.
-
The Functional and Molecular Effects of Doxycycline Treatment on Borrelia burgdorferi Phenotype.Front Microbiol. 2019 Apr 18;10:690. doi: 10.3389/fmicb.2019.00690. eCollection 2019. Front Microbiol. 2019. PMID: 31057493 Free PMC article.
-
Late Disseminated Lyme Disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques.Am J Pathol. 2018 Mar;188(3):672-682. doi: 10.1016/j.ajpath.2017.11.005. Epub 2017 Dec 12. Am J Pathol. 2018. PMID: 29242055 Free PMC article.
References
-
- Bigger JW. 1944. Treatment of staphylococcal infections with penicillin. Lancet 244:497–500. doi:10.1016/S0140-6736(00)74210-3. - DOI
-
- Tuomanen E, Tomasz A. 1990. Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics. Scand J Infect Dis Suppl 74:102–112. - PubMed
-
- Tuomanen E. 1986. Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria. Rev Infect Dis 8(Suppl 3):S279–S291. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical